Glaxosmithkline Pharmaceuticals Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹938.44 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 5.71 per cent from ₹995.30 crore. This corresponds to a year-on-year *(YoY) growth of 16.55 per cent.
Operating Profit
Operating Profit stands at ₹295.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.80 per cent from ₹350.93 crore. This corresponds to a year-on-year *(YoY) growth of 17.64 per cent.
PBDT
PBDT stands at ₹338.29 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.42 per cent from ₹386.27 crore. This corresponds to a year-on-year *(YoY) growth of 14.87 per cent.
Profit Before Tax
Profit Before Tax stands at ₹322.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.58 per cent from ₹373.10 crore. This corresponds to a year-on-year *(YoY) growth of 15.58 per cent.
Net Profit
Net Profit stands at ₹237.18 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 14.64 per cent from ₹277.86 crore. This represents a 15.69 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Glaxosmithkline Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Glaxosmithkline Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Glaxosmithkline Pharmaceuticals Ltd Research Reports
Glaxosmithkline Pharmaceuticals Ltd Financial Reports
Glaxosmithkline Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Glaxosmi. Pharma | 1.59% | 0.92% | 18.72% | 31.57% | 17.80% | 10.17% |
| Alkem Lab | -0.21% | -1.19% | -4.95% | -2.13% | -5.37% | -0.75% |
| Abbott India | -0.07% | 1.54% | -4.73% | -4.37% | 0.01% | -15.86% |
| Anthem Bioscienc | 5.78% | 5.65% | 16.94% | 22.10% | 31.87% | 13.06% |
| Ipca Labs. | 0.58% | 2.70% | 9.80% | 24.15% | 27.43% | 37.06% |
| Gland Pharma | 2.48% | 2.83% | 19.59% | 25.51% | 59.27% | 53.90% |
| Ajanta Pharma | -0.35% | -3.18% | 4.88% | 17.34% | 18.50% | 41.29% |
Company Info
Company Information
Chairman & Non Executive Dir. : Renu S. Karnad
Managing Director : Bhushan Akshikar
Independent Non Exe. Director : Manu Anand
Independent Non Exe. Director : Sunita Maheshwari
Independent Non Exe. Director : Somasundaram Palamadairamaswamy
Independent Non Exe. Director : Anup Wadhawan
Whole Time Director & CFO : Ronojit Biswas
VP / Company Secretary / Compliance Officer : A A Nadkarni
Non Executive Director : Karine J F Natland